Naaju Breaking News, Live Updates, Latest Headlines, Viral News, Top Stories, Trending Topics, Videos
[ad_1]
After Denmark, Norway announce suspension of covid-19 vaccine of AstraZeneca Because some people who have been given it have reported having clots, it remains to be wondered if it is a safe vaccine.
Although local health officials have indicated that the suspension was due to a “precautionary” measure and that, for now, there is no direct relationship between thrombosis and vaccine.
However, it is an episode that increases “negative publicity” around the Swedish-British pharmaceutical multinational, already in the media spotlight due to delays in the production of the vaccine (produced in collaboration with the University of Oxford).
What we know so far is that the AstraZeneca vaccine has several advantages: it is much cheaper and easier to manage than those from Pfizer and Moderna, and has received the green light from several regulatory bodies: the UK, the EU and the World Health Organization (WHO).
According to experts, it causes only mild or moderate side effects, and it is safe and effective in preventing COVID-19.
It is based on a genetically modified chimpanzee cold virus
“Reports of blood clots received so far are no greater than the number that would have occurred naturally in the vaccinated population.”says Dr Phil Bryan, head of vaccine safety at the UK Medicines and Health Products Regulatory Agency.
In any case, despite what has been confirmed by scientists, Danish health authorities on Thursday announced the suspension of AstraZeneca vaccines following reports of a death in the country. However, they pointed out that “At this time, it cannot be concluded whether there is a relationship between the vaccine and these incidents of thrombosis.”
Their Norwegian counterparts also chose to stop vaccinating after the Danish report. Both options will impact your respective immunization programs.
“It was not concluded that there is a link between the vaccination and the incident in Denmark, but, as a precaution, we have chosen to suspend the vaccination of AstraZeneca for the duration of the investigation,” said Geir Bukholm, Director of Prevention. and infection control by the Norwegian Institute of Public Health.
In turn, Austria has also suspended a batch of vaccines after the death of a woman as a result of blood clots, as well as the hospitalization of another person with a thrombus in the pulmonary arteries.
The vaccine batch, which included one million doses delivered to 17 EU countries, has been suspended in four other states as a precaution: Estonia, Lithuania, Luxembourg and Latvia.
The European Medicines Agency (EMA), according to Euronews, is examining these incidents, along with all other “blood clot-related conditions,” but reports that on preliminary examination, there does not appear to be a “specific problem” with the batch of vaccine in question.
The EMA reports that on Tuesday there were 22 cases of blood clots among three million people vaccinated with the AstraZeneca vaccine in the European Economic Area.
For their part, company representatives said that “An analysis of our safety data on over 10 million cases showed no evidence of an increased risk of pulmonary embolism or deep vein thrombosis in any age group, sex, lot or country in particular.”
.
[ad_2]
Source link
